| Fertility and infertility: Definition and epidemiology |
118 |
| The multiple functions and mechanisms of osteopontin |
40 |
| Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease |
23 |
| Hair cortisol analysis: An update on methodological considerations and clinical applications |
22 |
| Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis |
20 |
| Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department |
20 |
| Droplet digital PCR improves urinary exosomal miRNA detection compared to real-time PCR |
17 |
| A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness |
15 |
| Data science, artificial intelligence, and machine learning: Opportunities for laboratory medicine and the value of positive regulation |
12 |
| Serum interleukin measurement may help identify thyroid cancer patients with active disease |
11 |
| Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer |
11 |
| Alzheimer's disease in the omics era |
11 |
| Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer |
10 |
| Best practices in mitigating the risk of biotin interference with laboratory testing |
10 |
| Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation |
10 |
| Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview |
10 |
| Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood |
10 |
| Clinical aspects of Alzheimer's disease |
9 |
| Elecsys (R) Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid |
9 |
| What information on measurement uncertainty should be communicated to clinicians, and how? |
9 |
| Paper spray mass spectrometry for the direct, semi-quantitative measurement of fentanyl and norfentanyl in complex matrices |
8 |
| Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results |
8 |
| Random uncertainty of photometric determination of hemolysis index on the Abbott Architect c16000 platform |
8 |
| Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay |
8 |
| The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation |
8 |
| Data mining: Seasonal and temperature fluctuations in thyroid-stimulating hormone |
8 |
| Method comparison study of the Elecsys (R) beta-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS |
7 |
| IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring? |
7 |
| Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma |
7 |
| Peaks and tails: Evaluation of irregularities in capillary serum protein electrophoresis |
7 |
| Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working Group |
7 |
| Analytical performance of an immunoassay to measure proenkephalin |
7 |
| An approach to analytical validation and testing of body fluid assays for the automated clinical laboratory |
7 |
| Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease |
7 |
| Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting |
7 |
| ICP-MS measurement of toxic and essential elements in human breast milk. A comparison of alkali dilution and acid digestion sample preparation methods |
7 |
| Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters |
7 |
| Comparison of fasting and non-fasting lipid profiles in a large cohort of patients presenting at a community hospital |
7 |
| Differential expression of miR-155 and Let-7a in the plasma of childhood asthma: Potential biomarkers for diagnosis and severity |
7 |
| Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis |
7 |
| Serum and dietary zinc and copper in Iranian girls |
7 |
| Towards salivary C-reactive protein as a viable biomarker of systemic inflammation |
6 |
| Corticotropin hormone assay interference: A case series |
6 |
| Diagnostic concordance between NT-proBNP and BNP for suspected heart failure |
6 |
| A primer on patient-based quality control techniques |
6 |
| Effects of co-existing autoimmune diseases on serum lipids and lipoprotein subclasses profile in paediatric patients with type 1 diabetes mellitus |
6 |
| New molecular approaches to Alzheimer's disease |
6 |
| Defining permissible limits for the combined uncertainty budget in the implementation of metrological traceability |
6 |
| Further assessment of the prevalence of biotin supplementation and its impact on risk |
6 |
| Establishment of reference intervals for the salivary cortisol circadian cycle, by electrochemiluminescence (ECLIA), in healthy adults |
6 |
